Activity of the quinupristin-dalfopristin combination (RP-59500; Synercid) tested against vancomycin-resistant Enterococcus species.
Cormican
M G
MG
Johnson
D M
DM
Jones
R N
RN
D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use*; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D016983:Enterococcus / Q000187:drug effects*; D013293:Enterococcus faecalis / Q000187:drug effects; D016984:Enterococcus faecium / Q000187:drug effects; D016908:Gram-Positive Bacterial Infections / Q000188:drug therapy*; D014640:Vancomycin / Q000494:pharmacology; D014769:Virginiamycin / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D004338:Drug Combinations; D014769:Virginiamycin; C062940:quinupristin-dalfopristin; D014640:Vancomycin